Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 4Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Genitourinary 2Breast 2Thoracic 1Plasma cell 1Other solid neoplasm 1Myeloid 1Gynecologic 1Gastrointestinal 1CNS 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Mesothelioma, Malignant 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1Anus Neoplasms 1

Interventions

Cisplatin 60Carboplatin 55Cyclophosphamide 47Pemetrexed 45Irinotecan 33pembrolizumab 32Paclitaxel 29Etoposide 29Gemcitabine 28Nivolumab 24Bevacizumab 24Interviews as Topic 23Vincristine 22Capecitabine 22Topotecan 20Filgrastim 20Early Intervention, Educational 20fludarabine 19Oxaliplatin 19Docetaxel 19Specimen Handling 18Drug Therapy 18Temozolomide 17Sorafenib 17Leucovorin 17Everolimus 17Educational Status 17Radiotherapy 16Methods 16Fluorouracil 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Interleukin-12 Subunit p35 × Other solid neoplasm × Clear all
NCT00003046 2012-07-30

Interleukin-12 in Treating Patients With Cancer in the Abdomen

M.D. Anderson Cancer Center

Phase 1 Completed
29 enrolled
GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Gallbladder Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡